Missling Christopher U
- SEC CIK
- 0001196573
No open-market purchases or sales filed in the past year.
Current role at each company
- AVXL Anavex Life Sciences Corp.President and CEOas of Jan 9, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Missling Christopher U as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 (view filing) | Mar 28 | 4 days | Missling Christopher UPresident and CEO | SSale | −73.4K | $5.11 | −$375.0K | −5.5%1.25M after | |
| Jun 30, 2023 (view filing) | Jun 28 | 2 days | Missling Christopher UPresident and CEO | SSale | −268.0K | $7.98 | −$2.14M | −20.8%1.02M after | |
| Jul 1, 2021 (view filing) | Jun 29 | 2 days | Missling Christopher UPresident and CEO | SSale | −51.6K | $26.00 | −$1.34M | −4.8%1.02M after |